Biotech
Browse the latest news about Southern California's biotech startups and ecosystem from dot.LA.

ImmixBio, a West L.A.-based startup developing cancer therapies, announced on Friday it submitted a confidential filing to go public.

Ilya Rachman, chief executive of the nine-year-old company which has developed a combination therapy meant to prevent cancers from resisting treatments and evolving, would not specify how many shares will be offered or the price range.

Read more Show less

It may just be symbolic, but the two-year-old gene therapy Capsida Biotherapeutics built its manufacturing site in the shadow of pharma giant Amgen's headquarters, a wink to its greater ambitions.

Read more Show less

When Matt Kozlov, TechStars Los Angeles' Managing Director, evaluates startups, he looks for a few key qualities in a company's leadership: humility, passion, resilience and the ability to accept coaching well.

Read more Show less

Trending